MiRNA-375 inhibits retinoblastoma progression through targeting ERBB2 and inhibiting MAPK1/MAPK3 signalling pathway-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

MiRNA-375 inhibits retinoblastoma progression through targeting ERBB2 and inhibiting MAPK1/MAPK3 signalling pathway

Published:2021-10-29 Issue: Volume: Page:1-10
ISSN:1556-9527
Container-title:Cutaneous and Ocular Toxicology
language:en
Short-container-title:Cutaneous and Ocular Toxicology

Author:

Liu Lei¹,Xiao Chunlin²,Sun Qiuyun³^ORCID

Affiliation:

1. Department of Fundus Disease, Aier Eye Hospital Chongqing Children’s, Chongqing City, China

2. Department of Ocular Surface and Cornea, Chongqing Aier Eye Hospital, Chongqing City, China

3. Department of Oculoplasty & Lacrimal System, Chongqing Aier Eye Hospital, Chongqing City, China

Publisher

Informa UK Limited

Subject

Toxicology,General Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1080/15569527.2021.1994587

Reference42 articles.

1. Challenging the global retinoblastoma survival disparity through a collaborative research effort

2. Predictors of long-term visual outcome after chemoreduction for management of intraocular retinoblastoma

3. Causes and consequences of microRNA dysregulation in cancer

4. MicroRNAs: Target Recognition and Regulatory Functions

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. MiR‐452‐5p facilitates retinoblastoma cell growth and invasion via the SOCS3/JAK2/STAT3 pathway;Journal of Biochemical and Molecular Toxicology;2023-08-26

2. CircZFR promotes pancreatic cancer progression through a novel circRNA-miRNA-mRNA pathway and stabilizing epithelial-mesenchymal transition protein;Cellular Signalling;2023-07

3. Drugging Hijacked Kinase Pathways in Pediatric Oncology: Opportunities and Current Scenario;Pharmaceutics;2023-02-16

4. Recent Approaches in Magnetic Nanoparticle-Based Biosensors of miRNA Detection;Magnetochemistry;2023-01-06

5. Research Hotspots and Development Trend of microRNA-375 in Hepatocellular Carcinoma—Based on Bibliometric and Visualization Analysis;Advances in Clinical Medicine;2023

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3